Bryanna Cordeiro, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 305 N Main St, Ennis, MT 59729 Phone: 406-682-4223 |
Brandon S Allen, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 305 N Main St, Ennis, MT 59729 Phone: 406-682-4223 Fax: 406-682-4756 |
Robert D Marks, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 E Main St, Ennis, MT 59729 Phone: 406-682-4223 Fax: 406-682-3874 |
Jaye T Swoboda, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 219 North Main St, Ennis, MT 59729 Phone: 406-682-4223 Fax: 406-682-3874 |
Dustin Brown, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 N Main St, Ennis, MT 59729 Phone: 406-682-4223 Fax: 406-682-4756 |
Dr. Carson Curtis Blake, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 305 N. Main, Ennis, MT 59729 Phone: 406-682-6862 |
News Archive
Pioneering neural recordings in patients with Parkinson's disease by UC San Francisco scientists lays the groundwork for personalized brain stimulation to treat Parkinson's and other neurological disorders.
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.
Young adults with thalassemia and sickle cell diease have been trying for up to 10 years to gain admission to the only adult hospital program in central and southwestern Toronto specialized to treat their blood disorders. Since 1999, the Toronto General Hospital (TGH) has restricted the inherited blood disorders program to 99 patients requiring blood transfusions. As a result, about 150 young adults with complex disorders receive blood transfusions at the Hospital for Sick Children but no adult services.
A new nano-fabricated platform for observing brain cancer cells provides a much more detailed look at how the cells migrate and a more accurate post-surgery prognosis for brain cancer (glioblastoma) patients.
Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that p300, a protein that increases gene expression by attaching acetyl molecules to DNA, may stop myelodysplastic syndrome (MDS) from developing into acute myeloid leukemia (AML). The study was published in the journal Leukemia.
› Verified 7 days ago